Share the Video:

Building the next generation of psychedelic retreat centers

Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison

While clinical access to psychedelics in the US and many other countries remains limited to ketamine and research studies, retreat centers are already operating throughout the world. Even within the US, Oregon and Colorado stand poised to regulate service centers, many of which are sure to follow the retreat center model. What can we learn from those who are offering access to psychedelic experiences in these venues, and how do they differ from the context of clinical medicine?

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study)

The POIESIS study explores how self-identity dimensions influence preferences in a psychedelic dosing environment. Initial findings show stronger connections to spiritual/religious identity compared to racial/ethnic identity. Ongoing efforts aim to

Cody J Wenthur

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2023 Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Resources for Therapists

Improving study design in trials using psychedelic-assisted therapies

Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.

Ingmar Gorman, Erika Dyck, Tehseen Noorani

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research

Visionary Women: Transforming Psychedelic Medicine

Vicky Dulai of Compassion For Addiction moderates a discussion with Amy Emerson of MAPS Public Benefit Corporation and Rachel Yehuda of Icahn School of Medicine on leadership in the psychedelic

Rachel Yehuda

PS2023 Healing for All Integration Psychedelic Assisted Therapy Psychedelic Science Research Therapy Ethics

Psychedelics, Conflict Resolution & Restorative Justice

Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.

PS2023 Healing for All Integration Psychedelic Assisted Therapy Psychedelic Science Psychotherapy Research

The Love Project: Preliminary outcomes of a survey study among psychedelic users

Psychedelic-assisted therapy commonly involves experiences of self-love, love towards others, love received, and being in love. Research explores these experiences' healing potential and integration in therapy.

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social and Cultural

Psychedelic education today: kids, parents, and the public

Panel discusses equipping parents with youth drug use info, fostering open conversations, and addressing public perception. Transformative drug education empowers communities, dismantles stigma, and cultivates informed society.

Vilmarie Narloch, Rhana Hashemi, Stefanie Jones, Gina Giorgio

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research

Preview Scene from Prescription X: The Rick Doblin and MAPS Documentary (Work in Progress)

"Prescription X: The Rick Doblin Story" documents Dr. Rick Doblin's quest with MAPS to legalize MDMA and psychedelics for therapy, culminating in a revealing film by Nirvan and Dream Mullick.

Nirvan Mullick, Dream Mullick

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Social and Cultural Spirituality

Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse

Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made

Robert Jesse, Michael Pollan

Building the next generation of psychedelic retreat centers

Become a MAPS Member with a monthly donation

Related Videos